|
PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts) with biochemically recurrent prostate cancer (PCa): A phase III study (CONDOR)—A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth. |
|
|
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Genzyme; Janssen; Pfizer; Sanofi |
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Genzyme; Janssen; Pfizer; Progenics; Sanofi |
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Sanofi |
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Sanofi |
Patents, Royalties, Other Intellectual Property - Transcriptional system and uses therof for single cell detection |
Other Relationship - Merck; Progenics |
|
|
Research Funding - Progenics (Inst) |
|
|
Stock and Other Ownership Interests - Precision Molecular |
Research Funding - Progenics (Inst) |
Travel, Accommodations, Expenses - Progenics |
|
|
Research Funding - Progenics (Inst) |
|
|
Research Funding - Progenics (Inst) |
|
|
No Relationships to Disclose |
|
|
Research Funding - Accuray (Inst); Accuray (Inst) |
|
|
Consulting or Advisory Role - Blue Earth Diagnostics |
Research Funding - Progenics (Inst) |
|
|
Consulting or Advisory Role - Blue Earth Diagnostics; Focus-X Therapeutics; Progenics |
Research Funding - Advanced Accelerator Applications (Inst); GE Healthcare (Inst); Progenics (Inst) |
Other Relationship - Radmetrix |
|
|
Employment - Blueberry Pediatrics (I) |
Research Funding - Progenics (Inst) |
|
|
Research Funding - Progenics (Inst) |
|
|
Consulting or Advisory Role - Isotopen Technologien |
Research Funding - Advanced Accelerator Applications (Inst); GE Healthcare (Inst); Progenics (Inst) |
Travel, Accommodations, Expenses - GE Healthcare |
|
|
Stock and Other Ownership Interests - Johnson & Johnson |
Research Funding - Endocyte |
|
|
|
|
Stock and Other Ownership Interests - Progenics |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Progenics |
|
|
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Curium Pharma; Curium Pharma; Endocyte; Johnson & Johnson; ORIC Pharmaceuticals |
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Janssen (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Endocyte; Fujifilm |
|
|
|
Consulting or Advisory Role - AVID Radiopharmaceuticals; Curium Pharma; GE Healthcare; ImaginAb; Progenics |
Research Funding - Blue Earth Diagnostics (Inst); ImaginAb (Inst); Progenics (Inst) |
Travel, Accommodations, Expenses - Blue Earth Diagnostics; ImaginAb; Progenics; Siemens (I) |